Grégory Chapron
Geschäftsführer bei Splio SAS
Profil
Grégory Chapron is currently the Chief Operating Officer at Splio SAS since 2020.
Previously, he worked as the Chief Financial Officer at Domain Therapeutics SA and as a Manager at Sirene Capital Oy.
He also served as the Chief Financial Officer at Nextedia SA from 2005 to 2008.
Mr. Chapron completed his undergraduate studies at École des Hautes Études Commerciales de Paris and AgroParisTech.
Aktive Positionen von Grégory Chapron
| Unternehmen | Position | Beginn |
|---|---|---|
Splio SAS
 Splio SAS Packaged SoftwareTechnology Services Splio SAS provides computer programming services. Its application delivers an online and offline customer loyalty marketing to manage marketing campaigns and loyalty programs. The company was founded by Raphael Jore and Louis Rouxel in 2001 and is headquartered in Paris, France. | Geschäftsführer | 01.11.2020 |
Ehemalige bekannte Positionen von Grégory Chapron
| Unternehmen | Position | Ende |
|---|---|---|
| NEXTEDIA | Finanzdirektor/CFO | 01.01.2008 |
Sirene Capital Oy
 Sirene Capital Oy Electronics DistributorsDistribution Services Sirene Capital Oy develops software products and solutions. The company was founded by Tuomas Petri Juhani Fabritius and Mikko Alasaarela on June 1, 1999 and is headquartered in Oulu, Finland. | Corporate Officer/Principal | - |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Finanzdirektor/CFO | - |
Ausbildung von Grégory Chapron
| AgroParisTech | Undergraduate Degree |
| École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEXTEDIA | Commercial Services |
| Private Unternehmen | 3 |
|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Sirene Capital Oy
Sirene Capital Oy Electronics DistributorsDistribution Services Sirene Capital Oy develops software products and solutions. The company was founded by Tuomas Petri Juhani Fabritius and Mikko Alasaarela on June 1, 1999 and is headquartered in Oulu, Finland. | Distribution Services |
Splio SAS
Splio SAS Packaged SoftwareTechnology Services Splio SAS provides computer programming services. Its application delivers an online and offline customer loyalty marketing to manage marketing campaigns and loyalty programs. The company was founded by Raphael Jore and Louis Rouxel in 2001 and is headquartered in Paris, France. | Technology Services |
